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Abstract Clear cell renal cell carcinoma (ccRCC) is the
major and aggressive subtype of renal cell carcinoma. It is
known to derive its histologic appearance from accumu-
lation of abundant lipids and glycogens. The cell death-
inducing DFF45-like effector (CIDE) family has been
characterized as the lipid droplet proteins involved in the
metabolism of lipid storage droplets. The purpose of this
study was to evaluate the expression of CIDE proteins in
ccRCC cells and to investigate their prognostic signifi-
cance. We examined consecutive patients with sporadic
ccRCC, who underwent nephrectomy, to measure their
mRNA and protein expression of CIDE proteins. We found
that Cidec and ADRP expression were significantly up-
regulated in ccRCC, compared with normal kidney tissues.
Cideb was down-regulated. We also found that Cideb was
expressed more in low-grade ccRCC than in high-grade
tumors. To further clarify the relationship between Cideb
expression and patient prognosis, we evaluated 57 ccRCC
patients followed up for 120 months. Reduced ccRCC
Cideb expression was associated with a higher Fuhrman
nuclear grade. Patients with high Cideb expression had
better overall survival rate than those with low expression
(p \ 0.05). Cideb expression was an independent predictor
of survival (p = 0.001). Although the biologic function of
Cideb in ccRCC remains unknown, the expression level of
Cideb might be a novel predictor of prognosis in ccRCC.
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Introduction
Renal cell carcinoma (RCC) is the most common malig-
nant tumor in the adult kidney, accounting for about 3 % of
human malignancies [1]. On the basis of current genetic
knowledge and histologic findings, RCC can be classified
into at least four major subtypes: clear cell (ccRCC),
papillary, chromophobe, and collecting duct carcinoma [2,
3]. Among them, ccRCC represents the most common
subtype (83 %) [4]. Unfortunately, ccRCCs show an
extremely variable clinical course, which cannot be pre-
dicted. Additional prognostic markers are needed for a
more accurate determination of the prognosis and the
improvement of therapeutic strategies.
Clear cell RCC is characteristically of a bright golden
color, and the clear appearance of tumor cells is due to
cellular storage of lipid and glycogen [5–7]. Some epide-
miologic studies have shown that obesity is a risk factor for
RCC [8, 9]. In general, previous studies suggested that
obese patients (with a BMI [30 kg/m2) were associated
with a high proportion of ccRCC [10–12]. It is apparent
that ccRCC cells possess some abnormalities in the
metabolism of lipids and glycogen.
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The cell death-inducing DFF45-like effector (CIDE)
family has been characterized as the crucial lipid droplet
(LD) proteins involved in the formation and stabilization of
lipid storage droplets [13, 14]. The CIDE family is com-
posed of three members: Cidea, Cideb, and Cidec (CIDE-3
or Fat-specific protein 27) [14]. Previous studies have
suggested that Cidea is predominantly expressed in brown
adipose tissue [15], and mammary glands [16], while Cidec
is expressed at high levels in white adipose tissue [17].
Cideb is strongly expressed in the liver and kidney, in both
mice and humans [18, 19].
The presence of abundant LDs suggests that LD proteins
are associated with the development of ccRCC. It has been
reported adipose differentiation-related protein (ADRP), a
LD protein, is highly up-regulated both at the transcrip-
tional and protein levels in ccRCC [20]. The role of CIDE
family proteins has not been evaluated. In this study, we
measured the CIDE family protein expression in ccRCC
using real-time quantitative PCR and western blot. CIDE
family expression levels were correlated with the malig-
nancy of ccRCC. We examined 57 consecutive patients
with ccRCC to evaluate Cideb expression level in primary
tumors and its prognostic significance.
Materials and methods
Tissue and antibody
Clear cell RCC and corresponding normal kidney samples
were collected from patients who underwent nephrectomy
at the Fourth Military Medical University and its affiliated
hospitals. Patients did not receive any preoperative therapy.
All specimens were snap-frozen with liquid nitrogen and
stored at -80 C for nucleic acid and protein extraction.
The histologic slides, stained with hematoxylin and eosin,
were reviewed to confirm nuclear Fuhrman grading. Writ-
ten informed consent was obtained for studying gene
expression. The study protocol was approved by the insti-
tutional ethics committee. The case series consisted of 10
fresh ccRCC tumors and 10 fresh normal renal tissue
specimens obtained from 10 patients. These tumors were
classified according to the Fuhrman’s nuclear system. Five
patients had low grade tumors (grade 1 and grade 2) and five
high grade tumors (grade 3 and grade 4). 57 pathologically
confirmed sporadic ccRCC patients, diagnosed from May
2001 to December 2003, were also identified: 15 tumors
were grade 1, 18 grade 2, 16 grade 3, and 8 grade 4. The
mean follow-up period was 52 months (range: 2–116). The
mean tumor size was 6.47 ± 2.97 cm (Mean ± standard
deviation). The mean patient age was 59 years (range
32–79).The clinicopathological data are summarized in
Table 1. Rabbit anti-Cidea and anti-Cidec polyclonal
antibodies were donated by Dr. Peng Li (Department of
Biological Sciences and Biotechnology, Tsinghua Uni-
versity, Beijing, China). Mouse anti-Cideb monoclonal was
generated by Dr Boquan Jin (Department of Immunology,
the Fourth Military Medical University, Shaanxi, China).
Anti-GAPDH and anti-b-tubulin antibody were purchased
from Abcam (Cambridge, MA, USA).
Oil Red O staining
The frozen sections of fresh renal tissues and ccRCC
samples were stained with Oil Red O. In brief, cryopre-
served tissues were cut into 10-lm sections, and fixed in
10 % formalin for 5 min. Sections were washed in 60 %
isopropanol for 2 min, then incubated in Oil Red O (Sigma,
USA) working solution for 15 min. The stained tissues
were washed using 60 % isopropanol, and then water, to
remove residual staining. Slides were counterstained in
hematoxylin for 2 min. The slides were mounted with
aqueous mounting media and glycerin jelly, and examined
under light microscopy.
Electron microscopy
The tissues for electron microscopy were fixed in 2.5 %
cold glutaraldehyde overnight, at 4 C. Tissues were then
rinsed for 1 h in cold phosphate buffer solution (PBS,
0.1 M, pH 7.4) and fixed in 1 % osmium tetroxide for 1 h.
Tissues underwent gradient acetone dehydration, were
Epon 812 resin embedded, and ultra-thin sections (70 nm)
were cut onto slides. Sections were stained with uranyl
acetate and lead citrate for JEM-1011 transmission electron
microscope observation.
RNA isolation, cDNA synthesis, and quantitative PCR
analysis
RNA was isolated from 10 frozen tumors and 10 normal
renal specimens, using Trizol reagent (invitrogen, USA),
according to the manufacturer’s instructions. RNA was
quantified using the Nanodrop ND-2000 spectrophotometer
(Nano-Drop Technologies, Rockland, DE, USA). Total
RNA was reverse transcribed using Super-Script II
Table 1 Clinical and histopathological characteristics
Fuhrman grade Patient (%) Gender Age (years)
Male Female Median Range
Grade 1 15 (14 %) 5 3 53 46–62
Grade 2 18 (48 %) 21 8 58 47–73
Grade 3 16 (23 %) 11 3 56 42–71
Grade 4 8 (15 %) 6 3 58 51–75
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(TaKaRa, Japan). Primers were designed from the
sequence of the human cDNAs, and primer sequences are
listed in Table 2. Quantitative PCR was performed using
the Steponereal-time PCR system (Applied Biosystems) in
a total volume of 25 ll with SYBR green (TaKaRa, Japan).
cDNAs were serially diluted to obtain five standard solu-
tions that were used in the PCR reaction to generate the
reference data. Stepone software was used to generate the
reference curve. In each experiment, at least three inde-
pendent reactions were performed to obtain the mean.
Samples were normalized by dividing by the number of
copies of GAPDH mRNA.
Immunohistochemistry
We had 57 pathologically confirmed ccRCC patients with
long-term follow-up, and obtained the patient’s formalin-
fixed paraffin-embedded specimens. All samples were de-
waxed in xylene three times for 5–10 min, rehydrated in
descending alcohol gradients for 5 min, and blocked for
endogenous peroxidase (3 %H2O2 in 80 %methanol) for
20 min. Antigen retrieval was performed using two treat-
ments in 10 mM sodium citrate in a microwave for 15 min.
After blocking non-specific antigen with normal goat serum
for 30 min, the slides were incubated with mouse anti-Ci-
deb monoclonal antibody (dilution at 1:200) overnight at
4 C. Slides were incubated with 100–200 ll of labeled
secondary antibody for 30 min at room temperature. Visu-
alization was performed using diaminobenzidine (DAB).
The slides were counterstained in hematoxylin for 2 min,
dehydrated in ethanol, and mounted. The Cideb expression
was evaluated in ccRCC. Low expression was considered as
absence or\20 % expression in RCC, and high expression
was considered as C20 % expression in RCC.
Western blot
From 10 frozen tumor tissues and 10 normal renal tissues,
total samples were separated in a 10 % SDS-PAGE gel and
transferred onto a Immobilon-Polyvinylidene fluoride
(PVDF) membrane (Millipore Corporation, MA, USA).
After blocking with 5 % skimmed milk, the membrane was
incubated with mouse anti-Cideb monoclonal antibody
(dilution at 1:2,000), rabbit anti-Cidea antibody (dilution at
1:1,000), rabbit anti-Cidec (dilution at 1:4,000), or mouse
anti-GAPDH (dilution at 1:1,000). After washing, mem-
branes were incubated for 1 h with a 1:5,000 dilution of
peroxidase-conjugated goat anti-rabbit or anti-mouse
immunoglobulin (Santa Cruz Biotechnology, Santa Cruz,
CA) and expression characterized by chemiluminescence.
Statistical analyses
Statistical analysis was performed using the SPSS 13.0
software. Statistical analyses were performed with inde-
pendent samples for t test and cox proportional hazards
regression model. p value \0.05 was considered as statis-
tically significant.
Results
Frequent lipid droplet accumulation in ccRCC
In the light microscope, numerous large Oil Red O-posi-
tive, big LDs were visible in ccRCC cells (Fig. 1b), while
normal renal tissues contained significantly fewer LDs
(Fig. 1a). Similarly, electron microscopy analysis further
confirmed the presence of abundant LDs in the samples of
clear cell RCC (Fig. 1c).
mRNA and protein levels of CIDE family in ccRCC
We determined CIDE protein and mRNA expression and
correlated it with ccRCC clinicopathological parameters.
As shown in Fig. 2a, the mRNA level of Cidec was
increased nearly sixfold in renal tumor tissues compared
Table 2 Primer sequences
Gene Primer sequences Genbank
Cidea Forward: CATGTATGAGATGTACTCCGTGTC NM_001279.3
Reverse: GAGTAGGACAGGAACCGCAG
Cideb Forward: AGCCAAAGCATTGGAGACCCTACT NM_014430.2
Reverse: TCTGACCAGACTGCAACACCATCA
Cidec Forward: TTGATGTGGCCCGTGTAACGTTTG NM_022094.2
Reverse: AAGCTTCCTTCATGATGCGCTTGG
ADRP/perilipin2 Forward: CTGAGCACATCGAGTCACATACTCT NM_001122.2
Reverse: GGAGCGTCTGGCATGTAGTGT
GAPDH Forward: GAAGGTGAAGGTCGGAGTC NM_002046.3
Reverse: GAAGATGGTGATGGGATTTC
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with normal renal tissues (p \ 0.001). In contrast, Cideb
mRNA expression in ccRCC decreased about threefold
(p \ 0.001) in comparison with normal renal tissue.
mRNA expression of Cidea in ccRCC increased about
1.46-fold (p = 0.643). Moreover, ADRP, a PAT member,
had about 20-fold higher expression (p \ 0.001) in ccRCC,
compared with the normal renal tissue (data not shown).
Similarly, the western blot showed that Cideb protein
expression was significantly lower in ccRCC, compared
with adjacent normal renal tissues. Cidec protein expres-
sion was increased in ccRCC, compared with adjacent
normal renal tissues (Fig. 2b). There was no obvious dif-
ference in the expressions of Cidea. These results demon-
strate that CIDE proteins, especially Cideb and Cidec,
correlated with LD accumulation in ccRCC.
Correlation of Cideb expression with ccRCC grading
It has been previously demonstrated that ccRCC with lower
nuclear grade shows a typical ‘‘clear-cell’’ appearance. As
nuclear grade increases, the cytoplasm becomes more
eosinophilic and its ‘‘clear-cell’’ character diminishes [21].
Based on nuclear Fuhrman grading, we divided the ccRCC
into two groups: low grade (Fuhrman grade 1 and 2) and
high grade (Fuhrman grade 3 and 4). When comparing real
time-PCR expressions of the CIDE family between low-
grade and high-grade tumors (Fig. 3a), a significant dif-
ference was found only in Cideb mRNA expression
(p = 0.018); Cideb mRNA expression was higher in low-
grade tumors than in high-grade tumors. There were no
significant differences in Cidea and Cidec expressions
(p = 0.217 and 0.386, respectively). Similar results were
found by western blot (Fig. 3b). These data suggest that
Cideb is correlated with ccRCC grade.
Correlation of Cideb expression with the prognosis
in ccRCC patients
To further demonstrate the prognostic significance of Ci-
deb in ccRCC, immunohistochemistry (IHC) was used to
detect the expression level of Cideb in 57 patients with
ccRCC. Cideb expression was diffuse and strong staining
in normal renal tubular epithelial cells (Fig. 4a). In ccRCC,
the cytosolic expression level of Cideb was obviously
lower compared with normal renal tissues (Fig. 4b–d).
Cideb immunostaining score decreased with the increasing
Fuhrman nuclear grade. Fuhrman nuclear grade 1 and
grade 2 ccRCC demonstrated high Cideb expression
(96.7 %, 30/31), while Fuhrman nuclear grade 3 and grade
4 ccRCC had low expression (92.3 %, 24/26).
To assess the prognostic significance of Cideb expres-
sion, we divided the ccRCC patients into two groups:
Fig. 1 Increased lipid droplets in ccRCC. Images of renal sections
stained with Oil Red O from normal renal and ccRCC (a, b). The red
color spots in Oil Red O staining represent the lipid droplets in the
ccRCC(B). scale bars 50 lm. c transmission electron micrograph of
renal sections from ccRCC(original magnification 95000). L,lipid
droplets. (Color figure online)
Fig. 2 a RT-PCR results of
CIDE family in ccRCC and
adjacent noncancerous tissues.
b Expression of CIDE protein in
ccRCC and adjacent
noncancerous tissues. b-tubulin
was used as an internal control
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those with high Cideb expression ([20 %), and those with
low Cideb expression (absence or \20 % positive cells).
Univariate analysis revealed a significantly shorter pro-
gression-free survival for patients with low Cideb
expression (RR, 2.906; 95 % CI, 1.377–6.132; p =
0.005). To evaluate whether low Cideb expression in
ccRCC was an independent predictor of overall survival, a
multivariate analysis was performed using the Cox pro-
portional hazard test. Low Cideb expression was an
independent prognostic factor for survival (p = 0.001,
Table 3). A Kaplan–Meier curve showed that patients
with low Cideb expression in their ccRCC had signifi-
cantly shorter cancer-specific survival than those with high
expression. This difference was apparent very early during
follow up (Fig. 5, p = 0.005).
Discussion
It is well known that the clear appearance of tumor cells
results from cellular storage of lipid and glycogen [7]. Clear-
cell RCC with lower nuclear grade show a typical ‘‘clear-
cell’’ appearance. However, as nuclear grade increases, the
‘‘clear-cell’’ character diminishes, and the number of LD
decreases. Some LD proteins (such as ADRP, adipose dif-
ferentiation-related protein or adipophilin) have been shown
to have a role in clear-cell renal carcinoma differentiation
[20]. The microvessel density in ccRCC tends to decrease as
the tumor grade increases [22, 23].
The CIDE family regulates lipid metabolism and plays
an important role in the development of metabolic disor-
ders including obesity, insulin resistance, and hepatic
Fig. 3 a Relative mRNA
expression by quantitative real-
time PCR analysis.*p = 0.018.
The data are shown as
mean ± SE. b Western blot
analysis of low grade and high
grade ccRCC
Fig. 4 Correlation between Cideb immunostain and Fuhrman nuclear grade in clear cell RCC. a liver(positive control) b normal renal c grade 1
ccRCC d grade 2 ccRCC e grade 3 ccRCC f grade 4 ccRCC (original magnification 9400)
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steatosis [15, 17, 24–26]. We identified CIDE family
members which were associated with LD storage in
ccRCC. Compared with normal kidney tissues, there was
significant up-regulation of Cidec and down-regulation of
Cideb in ccRCC, but little change in Cidea. Cidea was a
BAT-specific marker, while Cidec was most highly
expressed in WAT [14]; thus, the different ccRCC
expression levels suggest that the lipid storage in ccRCC is
more related to WAT than BAT. In addition, we observed
that the mRNA levels of Cidec in high-grade ccRCC was
slightly higher than that in low-grade ccRCC, but the
protein levels of Cidec were similar. Several possibilities
might be involved in the regulation of Cidec, such as
protein degradation, transcriptional regulation, etc.. Nor-
mally, Cideb is expressed at a high level in liver and kidney
tissues [18]. Although CIDE proteins have been shown to
regulate the biosynthesis and storage of LDs in adipocytes
and hepatocytes [14, 18, 25], the function of CIDE proteins
in ccRCC has not been determined.
It is well known that ccRCC contains abundant lipids in
the cytoplasm, including triglycerides, cholesterol esters,
and phospholipids. These lipids impart the typical gross
‘‘yellow’’ appearance [1, 21, 27]. We confirmed the
abundant lipid accumulation in ccRCC using Oil Red O
and electron microscopy. We found that Cidec protein
expression significantly increased, while Cidea expression
did not change in ccRCC, compared with normal renal
tissue. The different Cidea and Cidec expression levels in
ccRCC suggest that lipid storage in ccRCC is more related
to WAT than BAT. The down-regulation of Cideb in
ccRCC suggests it may prevent the formation of ccRCC
cells. We speculated that Cideb could promote lipid
secretion in renal cells, similar to its functions in liver cells
[18]. These data strongly suggest that the decreasing level
of Cideb protein is implicated in lipid uptake and storage in
clear-cell RCC. Moreover, Cideb expression levels were
likely to reflect microscopic morphologic appearances and
the degree of malignancy of clear-cell RCC.
Using IHC, we found that the expression of Cideb in
both grade 3 and grade 4 were lower than that in grade 1
and grade 2, while the protein level of Cideb in grade 1
were similar to grade 2. The differences of Cideb in the
ccRCC were similar to ADRP [28]. The higher Fuhr-
man nuclear grade was associated with poor prognosis
[29]. Multivariate analysis confirmed that reduction
in the expression of Cideb was an independent prog-
nostic factor related to shorter progression-free survival
(p = 0.001). Thus, low expression of Cideb might be
applied as a novel prognostic marker. Collectively, these
findings suggest that ccRCC has abnormal lipid metab-
olism. We observed that the expression of Cideb was
largely decreased at both mRNA and protein levels in
ccRCC. Our data indicate that the loss of Cideb
expression is an important event in lipogenesis and
progression of ccRCC.
The mechanism of abnormal lipid metabolism in ccRCC
has not been fully elucidated. It is noteworthy that lipo-
genesis is part of the malignant process in RCC [30]. In this
study, we have shown that low Cideb expression is corre-
lated with higher nuclear grade of the ccRCC and poor
clinical outcome. A further, larger study should be per-
formed to extend and validate the precise mechanism by
which Cideb regulates lipid metabolism and tumor pro-
gression in ccRCC.
Table 3 Univariate and multivariate analyses of cancer-specific survival in 57 patients with ccRCC
Characteristics Univariate analysis Multivariate analysis
RR 95 % CI P RR 95 % CI P
Age ([60/B60) 2.365 1.131–4.977 0.022 2.881 1.361–6.097 0.006
Gender (male/female) 0.403 0.140–1.157 0.091 X
Cideb expression (low/high) 2.906 1.377–6.132 0.005 3.444 1.612–7.356 0.001
Tumor size, cm (C6/\6) 1.361 0.664–2.791 0.400 X
RR risk ratio, 95 % CI 95 % confidence interval
Fig. 5 The association of survival with different levels of Cideb
expression is illustrated in 57 ccRCC patients (p \ 0.01). Patients
with high expression of Cideb had longer survival than those with low
expression of Cideb
150 Mol Cell Biochem (2013) 378:145–151
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